We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$15.6M
Cap. Flow
+$5.46M
Cap. Flow %
2.37%
Top 10 Hldgs %
6.97%
Holding
827
New
263
Increased
114
Reduced
126
Closed
324

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.45M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.42M
3
G icon
Genpact
G
+$1.42M
4
CHRW icon
C.H. Robinson
CHRW
+$1.34M
5
OGE icon
OGE Energy
OGE
+$1.31M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.44M
2
MDLZ icon
Mondelez International
MDLZ
+$1.42M
3
AVT icon
Avnet
AVT
+$1.21M
4
MRVL icon
Marvell Technology
MRVL
+$1.04M
5
XYZ
Block Inc
XYZ
+$987K

Sector Composition

Rank Sector Weight
1 Technology 21.25%
2 Consumer Discretionary 15.35%
3 Healthcare 13.63%
4 Industrials 12.99%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHEF icon
301
Chefs' Warehouse
CHEF
$4.5B
$308K 0.13%
+4,821
New +$286K
EVR icon
302
Evercore
EVR
$11.8B
$306K 0.13%
1,132
-384
-25% -$84.5K
CTRA
303
DELISTED
Coterra Energy
CTRA
$304K 0.13%
11,986
-3,315
-22% -$84K
CNH
304
CNH Industrial
CNH
$17.5B
$304K 0.13%
+23,449
New +$290K
MOD icon
305
Modine Manufacturing
MOD
$10.4B
$304K 0.13%
+3,084
New +$275K
NCNO icon
306
nCino
NCNO
$2.1B
$303K 0.13%
+10,836
New +$271K
POWI icon
307
Power Integrations
POWI
$3.61B
$299K 0.13%
+5,351
New +$275K
QDEL icon
308
QuidelOrtho
QDEL
$838M
$298K 0.13%
+10,323
New +$305K
REGN icon
309
Regeneron Pharmaceuticals
REGN
$80.8B
$297K 0.13%
566
-32
-5% -$17.9K
CINF icon
310
Cincinnati Financial
CINF
$27.1B
$296K 0.13%
+1,988
New +$285K
ATO icon
311
Atmos Energy
ATO
$28.8B
$294K 0.13%
1,906
-8
-0.4% -$1.24K
AAPL icon
312
Apple
AAPL
$4.57T
$292K 0.13%
1,423
-711
-33% -$144K
BPOP icon
313
Popular Inc
BPOP
$11.1B
$290K 0.13%
+2,629
New +$260K
RGEN icon
314
Repligen
RGEN
$9.25B
$287K 0.12%
+2,308
New +$294K
RARE icon
315
Ultragenyx Pharmaceutical
RARE
$2.55B
$287K 0.12%
+7,882
New +$284K
VSEC icon
316
VSE Corp
VSEC
$6.12B
$286K 0.12%
+2,185
New +$272K
TRV icon
317
Travelers Companies
TRV
$80.2B
$284K 0.12%
+1,063
New +$280K
HUN icon
318
Huntsman Corp
HUN
$1.77B
$284K 0.12%
27,280
+10,573
+63% +$129K
HIG icon
319
Hartford Financial Services
HIG
$39.3B
$283K 0.12%
+2,228
New +$277K
BBW icon
320
Build-A-Bear
BBW
$462M
$281K 0.12%
+5,453
New +$231K
RGA icon
321
Reinsurance Group of America
RGA
$16.1B
$279K 0.12%
+1,405
New +$274K
VNO icon
322
Vornado Realty Trust
VNO
$7.38B
$279K 0.12%
7,283
+1,122
+18% +$42K
APLS
323
DELISTED
Apellis Pharmaceuticals
APLS
$276K 0.12%
+15,939
New +$295K
DIS icon
324
Walt Disney
DIS
$181B
$276K 0.12%
+2,223
New +$231K
LSTR icon
325
Landstar System
LSTR
$6.21B
$275K 0.12%
+1,979
New +$274K
11 12
13
14 15

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Sherbrooke Park Advisers held 827 positions worth $230M, up 7.3% from $215M the previous quarter. Its ten largest holdings account for 7% of the portfolio.

Sherbrooke Park Advisers's Q2 2025 filing shows 263 new, 114 increased, 126 reduced and 324 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M. The largest sale was Merck, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Sherbrooke Park Advisers's largest Q2 2025 buy was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M.
  • Sherbrooke Park Advisers added most to CMS Energy in Q2 2025, an estimated $1.14M increase.
  • Sherbrooke Park Advisers's biggest Q2 2025 reduction was MasTec, cutting an estimated $947K.
  • Sherbrooke Park Advisers fully exited Merck in Q2 2025, selling an estimated $1.44M.
  • Sherbrooke Park Advisers's ten largest holdings make up 7% of its $230M portfolio in Q2 2025.
  • Sherbrooke Park Advisers opened 263 new positions and closed 324 in Q2 2025.
  • Sherbrooke Park Advisers's portfolio value rose 7.3% quarter-over-quarter to $230M.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.